CD160 and neoplasm: CD160 preferentially binds to the herpes virus entry mediator (HVEM), and engagement of CD160 with this ligand activates NK-cell function, causing increased IFN-γ and TNF-α secretion, and in the tumor microenvironment, the activation of CD160 on immune cells promotes target cell cytolysis (16).